Lidocaine spray (Andros Pharmaceuticals)

N/A

Report date: 2026/05/26 20:00:28

Base Information

Drug NameLidocaine spray (Andros Pharmaceuticals)
Drug Alias NameAPC101APC-101 (Andros Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit modulators
TargetsSodium channel alpha subunit
Therapy Area/IndicationsNeuritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAndros Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeuritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A